Vectors Research Management’s Sanofi SNY Stock Holding History

Vectors Research Management’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-166	Closed	-$8K	–	430
2022 Q2	$8K	Hold	166	–	–	﹤0.01%	398
2022 Q1	$9K	Sell	166 -1	-0.6%	-$52	﹤0.01%	371
2021 Q4	$8K	Buy	167 +100	+149%	+$4.95K	﹤0.01%	451
2021 Q3	$3K	Sell	67 -100	-60%	-$5.08K	﹤0.01%	450
2021 Q2	$9K	Hold	167	–	–	﹤0.01%	401
2021 Q1	$8K	Hold	167	–	–	﹤0.01%	352
2020 Q4	$8K	Hold	167	–	–	﹤0.01%	346
2020 Q3	$8K	Hold	167	–	–	﹤0.01%	313
2020 Q2	$9K	Hold	167	–	–	﹤0.01%	307
2020 Q1	$7K	Hold	167	–	–	﹤0.01%	334
2019 Q4	$8K	Hold	167	–	–	﹤0.01%	375
2019 Q3	$8K	Hold	167	–	–	﹤0.01%	311
2019 Q2	$7K	Hold	167	–	–	﹤0.01%	300
2019 Q1	$7K	Hold	167	–	–	﹤0.01%	307
2018 Q4	$7K	Hold	167	–	–	﹤0.01%	492
2018 Q3	$7K	Buy	+167	New	+$7.13K	﹤0.01%	353

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vectors Research Management's SNY Position: Q3 2022 in Review

Vectors Research Management sold out of Sanofi (SNY) in Q3 2022, closing a stake of 166 shares — an estimated $8K sold.

Vectors Research Management first reported a position in SNY in Q3 2018 and held it in 16 quarters. The position peaked at $9K in Q1 2022. 587 funds tracked by Wall St. Rank hold SNY as of Q3 2022.

Vectors Research Management reported no remaining Sanofi position as of Q3 2022 after selling out during the quarter.
Vectors Research Management sold 166 Sanofi shares in Q3 2022, an estimated $8K.
Vectors Research Management first reported a position in Sanofi in Q3 2018 and held it in 16 quarters.
Vectors Research Management's Sanofi position peaked at $9K in Q1 2022.
587 funds tracked by Wall St. Rank held Sanofi as of Q3 2022.

Based on Vectors Research Management's 13F filing for Q3 2022, filed 8 Nov 2022.